SCOPUS 정보 검색 플랫폼

Volumn 6, Issue 9, 2014, Pages 1121-1123

DOT1L-HES6 fusion drives androgen independent growth in prostate cancer

(7) Annala, Matti a,b Kivinummi, Kati a Leinonen, Katri a Tuominen, Joonas a Zhang, Wei c Visakorpi, Tapio a Nykter, Matti a

a Institute of Biosciences and Medical Technology (Finland)

b TAMPERE UNIVERSITY OF TECHNOLOGY (Finland)

c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; PROSTATE SPECIFIC ANTIGEN; TRANSCRIPTION FACTOR ERG; TRANSCRIPTOME; CHIMERIC PROTEIN; DOT1L PROTEIN, HUMAN; HES6 PROTEIN, HUMAN; METHYLTRANSFERASE; REPRESSOR PROTEIN;

ADULT; AGED; ALGORITHM; ARTICLE; BONE SCINTISCANNING; CANCER GROWTH; CASE REPORT; DOT1L HES6 FUSION GENE; FUSION GENE; GENE FUSION; GENE OVEREXPRESSION; GENOME ANALYSIS; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; LNCAP CELL LINE; MALE; MIDDLE AGED; ORCHIECTOMY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSURETHRAL RESECTION; DNA SEQUENCE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROSTATIC NEOPLASMS; TUMOR CELL LINE;

AGED; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT; HUMANS; MALE; METHYLTRANSFERASES; MIDDLE AGED; MUTANT CHIMERIC PROTEINS; PROSTATIC NEOPLASMS; REPRESSOR PROTEINS; SEQUENCE ANALYSIS, DNA;

EID: 84916937682 PISSN: 17574676 EISSN: 17574684 Source Type: Journal
DOI: 10.15252/emmm.201404210 Document Type: Article

Times cited : (17)

References (8)

1
- 84890078624
- Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade
- Arora VK, Schenkein E, Murali R, Subudhi SK, Wongvipat J, Balbas MD, Shah N, Cai L, Efstathiou E, Logothetis C et al (2013) Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade. Cell 155: 1309-1322
- (2013) Cell , vol.155 , pp. 1309-1322
- Arora, V.K.¹ Schenkein, E.² Murali, R.³ Subudhi, S.K.⁴ Wongvipat, J.⁵ Balbas, M.D.⁶ Shah, N.⁷ Cai, L.⁸ Efstathiou, E.⁹ Logothetis, C.¹⁰

2
- 84860168795
- Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets
- Beltran H, Rickman DS, Park K, Chae SS, Sboner A, MacDonald TY, Wang Y, Sheikh KL, Terry S, Tagawa ST et al (2011) Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets. Cancer Discov 1: 487-495
- (2011) Cancer Discov , vol.1 , pp. 487-495
- Beltran, H.¹ Rickman, D.S.² Park, K.³ Chae, S.S.⁴ Sboner, A.⁵ MacDonald, T.Y.⁶ Wang, Y.⁷ Sheikh, K.L.⁸ Terry, S.⁹ Tagawa, S.T.¹⁰

3
- 80054003528
- ChimeraScan: a tool for identifying chimeric transcription in sequencing data
- Iyer MK, Chinnaiyan AM, Maher CA (2011) ChimeraScan: a tool for identifying chimeric transcription in sequencing data. Bioinformatics 27: 2903-2904
- (2011) Bioinformatics , vol.27 , pp. 2903-2904
- Iyer, M.K.¹ Chinnaiyan, A.M.² Maher, C.A.³

4
- 70349086528
- Acheate-scute like 1 (Ascl1) is required for normal delta-like (Dll) gene expression and notch signaling during retinal development
- Nelson BR, Hartman BH, Ray CA, Hayashi T, Bermingham-McDonogh O, Reh TA (2009) Acheate-scute like 1 (Ascl1) is required for normal delta-like (Dll) gene expression and notch signaling during retinal development. Dev Dyn 238: 2163-2178
- (2009) Dev Dyn , vol.238 , pp. 2163-2178
- Nelson, B.R.¹ Hartman, B.H.² Ray, C.A.³ Hayashi, T.⁴ Bermingham-McDonogh, O.⁵ Reh, T.A.⁶

5
- 84899932412
- Hes6 drives a critical AR transcriptional program to induce castration resistant prostate cancer through activation of an E2F1-mediated cell cycle network
- Ramos-Montoya A, Lamb AD, Russell R, Carroll T, Jurmeister S, Galeano-Dalmau N, Massie CE, Boren J, Bon H, Theodorou V et al (2014) Hes6 drives a critical AR transcriptional program to induce castration resistant prostate cancer through activation of an E2F1-mediated cell cycle network. EMBO Mol Med 6: 651-661
- (2014) EMBO Mol Med , vol.6 , pp. 651-661
- Ramos-Montoya, A.¹ Lamb, A.D.² Russell, R.³ Carroll, T.⁴ Jurmeister, S.⁵ Galeano-Dalmau, N.⁶ Massie, C.E.⁷ Boren, J.⁸ Bon, H.⁹ Theodorou, V.¹⁰

6
- 0029011116
- Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer
- Taplin ME, Bubley GJ, Shuster TD, Frantz ME, Spooner AE, Ogata GK, Keer HN, Balk SP (1995) Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 332: 1393-1398
- (1995) N Engl J Med , vol.332 , pp. 1393-1398
- Taplin, M.E.¹ Bubley, G.J.² Shuster, T.D.³ Frantz, M.E.⁴ Spooner, A.E.⁵ Ogata, G.K.⁶ Keer, H.N.⁷ Balk, S.P.⁸

7
- 0028944138
- In vivo amplification of the androgen receptor gene and progression of human prostate cancer
- Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinänen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi O-P (1995) In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 9: 401-406
- (1995) Nat Genet , vol.9 , pp. 401-406
- Visakorpi, T.¹ Hyytinen, E.² Koivisto, P.³ Tanner, M.⁴ Keinänen, R.⁵ Palmberg, C.⁶ Palotie, A.⁷ Tammela, T.⁸ Isola, J.⁹ Kallioniemi, O.-P.¹⁰

8
- 84881610068
- FOXO3 shares common targets with ASCL1 genome-wide and inhibits ASCL1-dependent neurogenesis
- Webb AE, Pollina EA, Vierbuchen T, Urban N, Ucar D, Leeman DS, Martynoga B, Sewak M, Rando TA, Guillernot F et al (2013) FOXO3 shares common targets with ASCL1 genome-wide and inhibits ASCL1-dependent neurogenesis. Cell Rep 4: 477-491
- (2013) Cell Rep , vol.4 , pp. 477-491
- Webb, A.E.¹ Pollina, E.A.² Vierbuchen, T.³ Urban, N.⁴ Ucar, D.⁵ Leeman, D.S.⁶ Martynoga, B.⁷ Sewak, M.⁸ Rando, T.A.⁹ Guillernot, F.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.